Direct lineage reprogramming is a promising approach for human disease modeling and regenerative medicine, with poorly understood mechanisms. Here, we reveal a hierarchical mechanism in the direct conversion of fibroblasts into induced neuronal (iN) cells mediated by the transcription factors Ascl1, Brn2, and Myt1l. Ascl1 acts as an ''on-target'' pioneer factor by immediately occupying most cognate genomic sites in fibroblasts. In contrast, Brn2 and Myt1l do not access fibroblast chromatin productively on their own; instead, Ascl1 recruits Brn2 to Ascl1 sites genome wide. A unique trivalent chromatin signature in the host cells predicts the permissiveness for Ascl1 pioneering activity among different cell types. Finally, we identified Zfp238 as a key Ascl1 target gene that can partially substitute for Ascl1 during iN cell reprogramming. Thus, a precise match between pioneer factors and the chromatin context at key target genes is determinative for transdifferentiation to neurons and likely other cell types.
INTRODUCTION
The lineage identity of differentiated somatic cells is considered to be very stable because of rigid chromatin configurations, inheritable DNA modifications, and re-enforcing transcription factor networks (Vierbuchen and Wernig, 2012) . However, various experimental conditions, including nuclear transfer into oocytes, cell fusion, and overexpression of transcription factors, have been shown to overcome these epigenetic barriers and induce cell-fate reprogramming to both pluripotency and unrelated somatic cell fates (Graf and Enver, 2009; Jaenisch and Young, 2008; Vierbuchen and Wernig, 2011) . We recently discovered that three neuronal transcription factors Ascl1, Brn2, and Myt1l (BAM factors) are sufficient to convert mesodermal fibroblasts or endodermal hepatocytes into fully functional neuronal cells, termed induced neuronal (iN) cells (Marro et al., 2011; Vierbuchen et al., 2010) . The generation of human iN cells is much less efficient and requires additional factors, such as NeuroD1 or microRNAs (Ambasudhan et al., 2011; Pang et al., 2011; Qiang et al., 2011; Yoo et al., 2011) .
Our previous findings suggested that of the three factors, Ascl1 is the central driver of reprogramming because only Ascl1 is sufficient to induce immature iN cells in mouse embryonic fibroblasts (MEFs). In contrast, neither Brn2 nor Myt1l alone achieve any morphological changes in MEFs. However, when combined with Ascl1, Brn2 and Myt1l greatly improved the conversion efficiency and both were required for the induction of fully reprogrammed iN cells. Ascl1 is a well-studied proneural gene of the basic helix-loop-helix (bHLH) family of transcription factors that specifically bind DNA sequences containing an E-box motif (Bertrand et al., 2002) . It is prominently expressed in a subset of central and peripheral neural progenitors (Guillemot et al., 1993; Lo et al., 1991) . Overexpression of Ascl1 and related factors in the developing spinal cord induces rapid neuronal differentiation (Ma et al., 1999; Nakada et al., 2004) . Accordingly, Ascl1 mutant mice show severe defects in neurogenesis (Guillemot et al., 1993) . Ascl1 regulates and is regulated by the Notch pathway, which mediates lateral inhibition (Bertrand et al., 2002; Guillemot et al., 1993) .
The other two iN cell factors are less well characterized. Brn2 (also known as Pou3f2) belongs to the Pou-Homeodomain family of transcription factors. Brn2 is expressed in ventricular zone progenitor cells throughout the neuraxis and downregulated upon differentiation, except in cortical development, where it remains expressed in layer II/III and V pyramidal neurons (Dominguez et al., 2012) . Combined deletion of Brn1 and Brn2 in mice resulted in severe proliferation defects of cortical progenitor cells and migration defects of upper-layer neurons, ultimately leading to a disorganized and thinned cortex (Sugitani et al., 2002) . Very little is known about Myt1l. It contains multiple zinc finger domains of the Cys-Cys-His-Cys (C2HC) type that are thought to interact with DNA (Kim and Hudson, 1992) . Myt1l is expressed throughout the central and peripheral nervous system in early postmitotic neurons (Cahoy et al., 2008; Weiner and Chun, 1997) . Interestingly, the Xenopus ortholog of Myt1 family transcription factors X-Myt1 is required for proper neuronal differentiation and synergizes with proneural bHLH transcription factors to promote ectopic neurogenesis in nonneural ectoderm (Bellefroid et al., 1996) .
These observations argue that the three iN cell reprogramming factors promote neuronal differentiation in the context of a neural progenitor cell. It is, however, completely unclear how these factors can exert their proper function in distantly related cell types, such as fibroblasts. Both the chromatin configuration at neuronal genes and the expression of transcriptional coregulators are assumed to be unfavorable for neuronal induction because fibroblasts normally never give rise to neurons and the reprogramming factors were not evolutionarily selected to induce transdifferentiation.
Here, we used an integrative genomic approach to characterize the molecular mechanism governing the early phase of MEF-to-iN cell reprogramming.
RESULTS

BAM Factors Induce Rapid and Global Transcriptional Changes in Fibroblasts
To begin to elucidate the molecular mechanism underlying iN cell reprogramming, we have determined the genome-wide transcriptional changes by RNA sequencing (RNA-seq) at various time points of reprogramming ( Figure 1A ). In addition to control cells infected with rtTA virus and treated with doxycycline (dox), we have profiled MEFs 0 and 48 hr after the induction of the single or combined BAM factors with dox, as well as TauEGFP-FACSsorted early and late iN cells, day 13 and 22 after dox, respectively. We observed that 2,522 genes significantly changed expression over this time course (fold change > 2, p value < 0.05) (Figure 1B; Figures S2A and S2B available online) . Genes that increased expression were enriched for gene ontology (GO) terms associated with neuronal activity ( Figure 1C ).
We observed that many more genes were upregulated than downregulated at 48 hr when MEFs were infected with Ascl1 or all three factors, whereas Brn2 and Myt1l had subtle transcriptional effects when expressed alone ( Figures 1B and 7A ).
Principal component analysis (PCA) showed that Ascl1 uniquely underlies the top two principle components of gene expression in MEFs transduced with the BAM factors ( Figure S1C ). These data suggest that Ascl1 functions mainly as a transcriptional activator as had been proposed before (Castro and Guillemot, 2011) and that Ascl1 may be the strongest driver of the neuronal transcriptional program.
Genome-wide Maps of BAM Factor Occupancy Reveal Ascl1-Dominant Targeting Capacity Based on the extensive changes in transcription observed 48 hr after initiation of reprogramming, we performed chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) for all three BAM factors in MEFs 48 hr after induction of all three factors. We readily identified 5,902 significant Ascl1-occupied loci upon filtering high-quality peaks based on at least 20-fold enrichment and less than 5% FDR (Figure 2A ). In contrast, Brn2 and Myt1l ChIP-seq required substantial technical optimization (see Experimental Procedures; Figures S2B and S2C). Under optimized conditions, Brn2 ChIP-seq revealed 2,354 peaks with at least 5-fold enrichment and less than 5% FDR. Using the same criteria, Myt1l ChIP-seq showed only minimal occupancy, despite extensive crosslinking and sonication optimization and use of different epitope tagging strategies. After optimization, we identified 475 peaks with at least 2-fold enrichment and less than 5% FDR. Most of these putative Myt1l isolated sites colocalized with histone modifications associated with accessible chromatin ( Figure S2C ). We confirmed that overexpressed Myt1l is present in fibroblast nuclei by immunofluorescence and in the chromatin fraction by western blot. However, the relative abundance of Myt1l on chromatin was less than Ascl1 ( Figure S2A ).
Ascl1 Binds Similar Genomic Sites in Fibroblasts and Neural Progenitor Cells Independent of Brn2 and Myt1l
Given the apparent dominant role of Ascl1, we next asked whether the other two reprogramming factors are required for Ascl1 to access its genomic targets in fibroblasts. We determined the Ascl1 binding sites by ChIP-seq in MEFs 48 hr after infection with Ascl1 alone. Surprisingly, the pattern of binding was virtually identical to Ascl1 binding in the context of all three transcription factors, as the correlation was almost identical to that observed between two biological replicates of Ascl1 ChIPseq in BAM infected MEFs ($0.8) (Figures 3A and S3B) . We confirmed these findings by performing Ascl1 ChIP-qPCR with cells expressing Ascl1 alone, in combination with Brn2 or Myt1l, and with cells expressing all three factors ( Figure 3E ). Thus, exogenous Ascl1 can access its binding sites in fibroblasts without assistance from Brn2 or Myt1l.
To better characterize the nature of Ascl1 target sites in MEFs, we sought to determine its targets in a close to physiological context. During normal development, Ascl1 is expressed in a subset of neural precursor cells (NPCs) of the ventricular zone of the neural tube and is believed to instruct neuronal differentiation (Guillemot et al., 1993; Lo et al., 1991) . When overexpressed in the neural tube or cultured NPCs Ascl1 induces a rapid exit from the cell cycle and neuronal differentiation (Nakada et al., 2004) . We therefore determined the Ascl1 binding sites by ChIP-seq in NPCs with or without overexpressing Ascl1 for 18 hr. Unexpectedly, the comparison of those results to genome-wide binding site analysis of Ascl1 in MEFs revealed a highly similar occupancy with comparable affinity ( Figures 3A, 3C , and S3A-S3C).
As has been observed in genome-wide localization studies for Ascl1 and other bHLH transcription factors, the E-box motif CANNTG was highly enriched across its binding sites based on the MEME algorithm ( Figure 3B ) (Bailey et al., 2009 ). The CAGCTG motif was by far the most frequently bound E-box motif as seen for myogenic factor MyoD but surprisingly less so for the other proneural bHLH factor NeuroD2 (Fong et al., 2012) . We observed the largest fraction of binding sites in the body of genes (often intronic sequences) followed by intergenic and promoter regions ( Figure 2B ). Many of the genes that are bound by Ascl1 are members of the Notch pathway like Hes6, Dll1, and Mfng or are otherwise associated with neural development, such as NeuroD4 ( Figure 3D ).
Brn2 Is Mislocalized during the Early Stages of the Reprogramming
To better characterize the genomic sites bound by Brn2 in BAMinfected MEFs, we also determined the Brn2 target sites in cultured NPCs by ChIP-seq ( Figure 4A ). In contrast to Ascl1 targets, we found little overlap between Brn2 binding in fibroblasts and NPCs ( Figures 4B and 4C) . A POU-like motif was significantly enriched at Brn2 target sites in NPCs, but not in Brn2-bound sites in BAM-infected MEFs. Instead, an E-box motif was significantly enriched in a large fraction of these sites (Figure 4A ). Direct comparison of Brn2 and Ascl1 targets in BAM-infected MEFs confirmed a high degree of overlap ( Figure 2A ). This finding raises the possibility that Ascl1 actively recruits Brn2 to some of its targets. Figure 4D ). Only 29 of these 600 sites (equivalent to 0.7% of all Brn2 targets in MEFs+Brn2) remain Brn2-bound when Brn2 is expressed alone ( Figures 4D and S4A ). These results show that Ascl1 recruits Brn2 to many of its targets. We have confirmed the colocalization of Brn2 and Ascl1 on the fibroblast chromatin by reciprocal coimmunoprecipitation experiments. Chromatin immunoprecipitated with antibodies against Brn2 contained a substantial amount of Ascl1 in MEFs infected with both factors ( Figure 4E , middle panel). Consistent with the ChIP-seq data, chromatin pulled down with Ascl1 antibodies contained relatively less Brn2 ( Figure 4E , right panel). To define the window of Brn2 action during iN reprogramming, we generated Ascl1-inducible MEFs and infected them with Brn2 1 day before or 2 or 5 days after addition of dox. The neuronal complexity, measured as total neurite length, increased about 6-fold when Brn2 was added at days À1 and 2 and about 2-fold when added at day 5 (Figures 4F and S4B) . In summary, these data suggest that the vast majority of Brn2-bound sites in MEFs are nonphysiological, and in part Brn2 gains access to chromatin sites made accessible by Ascl1. Furthermore, they suggest that Brn2 is primarily needed for later stages of reprogramming by contributing to iN maturation even up to 5 days after initiation of iN reprogramming.
Unlike Brn2, Ascl1 Acts as a Pioneer Factor in Fibroblasts
The surprising discovery that Ascl1 binds similar target sites in BAM-infected MEFs as in NPCs raised the question of whether those genomic Ascl1 target sites are in an open (nucleosomefree) or closed (nucleosome-bound) state in fibroblasts before infection. Based on the crystal structure of MyoD, bHLH p-value 5.9E-1353 (legend continued on next page) transcription factors are predicted to only be able to bind nucleosome-free DNA (Ma et al., 1994) . To measure the nonnucleosomal fractions of the MEF genome, we performed formaldehyde-assisted isolation of regulatory elements followed by high throughput sequencing (FAIRE-seq) in uninfected MEFs (Giresi et al., 2007) . Strikingly, the FAIRE analysis showed that Ascl1 target sites in MEFs were on average substantially depleted of nucleosome-free DNA ( Figure 5A ). These results demonstrate that Ascl1 preferentially binds previously closed chromatin in MEFs as early as within 48 hr and thus fulfills the formal criteria of a pioneer transcription factor (Zaret and Carroll, 2011) .
To gain insight into the differential binding behaviors of Ascl1 and Brn2, we plotted the FAIRE signal from uninfected MEFs at the genomic sites bound by Brn2 in BAM-infected MEFs. We found that, in contrast to Ascl1, Brn2 targets sites in MEFs are predominantly nucleosome free ( Figure 5A ). We next sought to characterize the histone marks associated with Brn2 targeting in fibroblasts. We generated H3K27ac ChIP-seq data in MEFs and utilized previously published ChIP-seq data sets for the H3K4me1, H3K4me3, and H3K27me3 histone marks. Consistent with our observation that Brn2 mostly binds accessible chromatin, Brn2 bound sites in fibroblasts are enriched for ''active'' marks, such as H3K4me1, H3K4me3, and H3K27ac ( Figure 5B ). The chromatin configurations of the Myt1l targets are also associated with open and active chromatin as demonstrated by the significant enrichment for the ''active'' marks H3K4me3 and H3K27ac at the 475 high-confidence bound sites (Figures 2A, 2B , and 5C).
Given that, unlike Ascl1, Brn2 does not act as a pioneer factor, we then wondered whether the proper Brn2 targets in NPCs are perhaps closed in MEFs, which would explain why Brn2 is barred from binding there. Surprisingly, we found that, similar to the observed Brn2-bound sites in MEFs, the Brn2-target sites in NPCs are quite open in MEFs, although to a slightly lesser degree than in the factual binding sites in MEFs ( Figure 5D ). As expected, the Ascl1 targets in NPCs are in a preferentially closed state in MEFs ( Figures 5D and S5A) . Thus, nucleosome occupancy is neither predictive for Ascl1 nor for Brn2 binding in MEFs.
A ''Trivalent'' Chromatin State Predicts Accessibility of Ascl1 and Permissiveness for iN Cell Reprogramming among Different Cell Types Pioneer factors can access nucleosomal DNA, yet only a very small proportion of all binding sites present in the genome are actually bound by any given transcription factor. Furthermore, transcription factors (including the well-characterized FoxA pioneer factors) bind different sets of target sites depending on the cellular context (Zaret and Carroll, 2011) . Thus, additional parameters must exist that determine selective binding. We sought to explore whether a specific signature of pre-existing histone marks in MEFs is associated with Ascl1 target sites. Average enrichments values of the individual marks showed strong enrichment of H3K4me1, H3K27acetyl, and H3K9me3 at Ascl1 target sites based on binding in NPCs. In contrast, none of those histone marks were significantly enriched in MEFs at the sites in which Brn2 is bound in NPCs ( Figure 6A) .
We next devised a strategy to locate and quantify the trivalent chromatin state comprised of H3K4me1, H3K27ac, and H3K9me3. We wished to confirm the co-occurrence of these histone modifications in an unbiased manner because in particular the repressive mark H3K9me3 may not be expected to coexist with the active enhancer marks H3K4me1 and H3K27ac. We adapted a previously described Hidden Markov Model analysis tool ChromHMM (Ernst and Kellis, 2012) . ChromHMM was used to define unique combinations of chromatin marks genome-wide in MEFs based on the five available histone modifications, and we then calculated the enrichment of each of these states in a set of user-specified genomic sites (Ernst and Kellis, 2012) . This analysis revealed a specific MEF chromatin state (ChromHMM state 5) that is enriched at Ascl1 binding sites ( Figure 6B ). ChromHMM state 5 in MEFs represents the combination of high enrichment values for H3K4me1 and H3K27ac and low-to-intermediate enrichment levels of H3K9me3, which were also the three histone marks that showed a significant enrichment when averaged across all Ascl1 binding sites (in the following also referred to as ''trivalent chromatin state'') (Figure 6B) . Notably, the presence of H3K9me3 has been previously identified as ''poised'' enhancer mark with cell-type-specific control of enhancer activity (Zentner et al., 2011; Zhu et al., 2012) . Among MEFs, NPCs, human fibroblasts, and keratinocytes, this trivalent state ranges from 0.34%-1.7% of the genome. Of all HMM chromatin states, state 5 showed the highest enrichment at Ascl1 targets ( Figures S6A, S6B , S6H, and S6I). Sequential immunoprecipitation of mononucleosomes isolated from MEFs demonstrated the co-occurrence of the three chromatin states H3K27ac, H3K4me1, and H3K9me3 on single nucleosomes, validating the existence of the trivalent state ( Figure S6C ).
Although the genome-wide Ascl1 occupancy is highly similar in MEFs and NPCs, there is a small fraction of sites bound by Ascl1 in NPCs that are not bound in MEFs. Remarkably, those sites have about 2-fold lower enrichment for the trivalent chromatin state ( Figure S6D ). This finding is yet more correlative (D) In MEFs+BAM, 22.2% of Brn2 sites colocalize with Asc11, a significant difference (p < 0.0001 t test) to only 9.9% of Brn2 sites in NPC that colocalize with Asc11. Only 0.7% of Brn2 peaks in the MEFs+Brn2 data set overlap with Ascl1 target sites in MEFs+BAM. Peak overlap was determined by at least one base pair overlap between high confidence peaks. evidence that the trivalent chromatin state may favor access of Ascl1 to its target sites. To address this hypothesis experimentally, we asked whether the presence of a trivalent chromatin state could predict Ascl1 binding in other cell types. We first calculated the enrichment for histone signatures at putative Ascl1 binding sites across distinct cell types, for which iN cell reprogramming efficiency was known, based on Ascl1 targets in NPCs. At Ascl1 targets, our analysis predicts enrichment for a trivalent chromatin state in MEFs and human dermal fibroblasts (NHDF). Conversely, it predicts low levels in normal human keratinocytes (NHEK) (Figure 6C ). Therefore, we tested whether Ascl1 can access its cognate sites in human dermal fibroblast versus keratinocytes. Indeed, 48 hr after induction, the binding of Ascl1 to its predicted target sites was much higher in fibroblasts than in keratinocytes as determined by ChIP-qPCR, despite equivalent Ascl1 expression and IP efficiencies ( Figure 6E ). To verify these results in a global manner, we mapped Ascl1's genome-wide target sites in NHDF and NHEK cells ectopically expressing Ascl1 by ChIPseq ( Figure 6D ). As predicted by the trivalent state model, Ascl1 occupancy in NHDF is significantly enriched for the canonical Ascl1 E-box, indicating that it is on target. In contrast, in NHEK cells in which Ascl1 sites lack the trivalent chromatin state, Ascl1 occupied almost completely different, off-target sites that lacked the motif. Only about 5.3% of the most confident Ascl1-bound sites in NHEK contained an E-box motif when a de novo motif search was conducted. In accordance with these results, we have failed thus far to convert keratinocytes into iN cells using transcription factor combinations containing Ascl1, whereas fibroblasts and hepatocytes can be reprogrammed efficiently (Marro et al., 2011; Pang et al., 2011; Vierbuchen et al., 2010) .
We extended our analysis to make predictions for nine additional human cell types for which there were publicly available data for the same five chromatin marks ( Figure 6F ). We used ChromHMM software to define chromatin states in each cell type and then calculated the enrichment for the trivalent state at predicted Ascl1 target sites. We found that human skeletal muscle myoblasts have strong enrichment for the trivalent chromatin state at Ascl1 sites, whereas human osteoblasts showed low levels. Consistent with our predictions, human skeletal muscle myoblasts are reprogrammed with efficiencies similar to reprogramming human fibroblasts when transduced with Ascl1, Brn2, Myt1l, and NeuroD1 (Pang et al., 2011) , whereas only very few iN cells formed from infected osteoblasts ( Figures 6G and S6E) . The ability to predict reprogramming across cell types of previously unknown potential provides strong support for the importance of the trivalent chromatin state in Ascl1-mediated reprogramming.
Conversely, experimental disruption of the trivalent state correlated with impaired MEF reprogramming to iN cells. We expressed JmjD2d, a histone demethylase that ''erases'' H3K9me3 or a catalytically inactive point mutant JmjD2d (H189A) (Krishnan and Trievel, 2013; Shi and Whetstine, 2007; Whetstine et al., 2006; Zhu et al., 2012) in MEFs 2 days before Ascl1 infection. JmJD2d overexpression resulted in substantial demethylation and reduction of iN cells formed after 2 weeks ( Figure 6H ). The reduction of reprogramming may also be explained by other effects of JmjD2d. Finally, H3K9me3 can undergo further dynamic changes during iN reprogramming (Figures S6F and S6G ).
Ascl1 Target Genes Are Preferentially Induced during
Reprogramming, Unlike Brn2 Target Genes Next, we wanted to explore the possible downstream mechanisms that mediate iN cell reprogramming initiated by expression of the BAM factors. To accomplish this, we first correlated Ascl1 binding with transcriptional changes. Compatible with the prevailing notion that Ascl1 acts primarily as transcriptional activator, we found that most Ascl1 target genes are upregulated 48 hr after dox (Figures 7A and S7A) . Of the 790 genes that significantly change expression by 48 hr, 143 genes are bound by Ascl1, and 133 of those are induced. In contrast, we did not find a similar correlation for genes associated with Brn2 target sites ( Figure 7A ). Only 42 genes of the 790 genes that change expression were bound by Brn2 in BAM-infected MEFs. Moreover, Ascl1 does not require Brn2 or Myt1l as a cofactor to induce its target genes, because its 1,198 target genes are highly upregulated on average with or without coexpression of Brn2 and Myt1l at 48 hr and, importantly, remain induced throughout the entire reprogramming process ( Figure 7B ). In contrast, Brn2 promotes fewer transcriptional changes with only subtle upregulation of target genes ( Figures 7A and 7C ). In particular, we identified 454 MEF-specific Brn2 targets, which tend to be transiently induced but are eventually silenced in iN cells as well as in cortical neurons and NPCs ( Figure 7C ). From the small fraction of overlapping NPCs/MEFs Brn2 targets that actually contained a POU-motif, we identified 87 genes that are upregulated faster, remain expressed during reprogramming, and tend to be expressed in cortical neurons and NPCs ( Figure 7C, left panel) . Thus, most Brn2 targets show only transient expression changes, but a small, but distinct, set of Brn2 target genes in MEFs do contribute to long-term iN cell transcription.
iN Cell Reprogramming Is Mediated In Part by the Direct Ascl1 Target Gene Zfp238
Integrative analysis of our transcriptional data identified 25 transcription factors that were significantly upregulated by BAM factors and may mediate the iN cell reprogramming process. A literature survey revealed that as many as 12 of the 25 factors potentially play important roles in neural development. None of these 12 transcription factors could individually induce neuronal cells or improve iN efficiency when combined with Ascl1 ( Figure 7D ). However, when tested in combination with Myt1l, 1 of the 12 factors, the Ascl1 target gene Zfp238, could induce neuron-like cells ( Figures 2C, 7E , and 7F). Although these cells expressed the neuronal markers Tuj1 and MAP2, their morphology appeared less mature, and the overall efficiency of their generation was highly reduced compared with Ascl1 and Myt1l ( Figures 7E and 7F ). Electrophysiological characterization showed that Zfp238/Myt1l-iN cells had less mature passive and active membrane properties than did Ascl1/Myt1l-iN cells (Figures 7I and 7J) . A smaller fraction of Zfp238/Myt1l-iN cells could generate single or repetitive action potentials (see pie charts in Figure 7I ). Whereas action potential thresholds and amplitudes were similar, the total numbers of action potentials in response to various amounts of current injections were significantly reduced in Zfp238/Myt1l-iN cells (Figures 7Ji-Jiii) . Moreover, their resting membrane potential was depolarized, their capacitance decreased, and their input resistance increased compared to Ascl1/Myt1l-iN cells (Figures 7Jiv-Jvi) . Na + currents were not significantly different between the two conditions ( Figures S7B  and S7C) . Thus, the single transcription factor Zfp238 mediates an important component of the transcriptional output of Ascl1 together with other critical downstream factors.
In order to identify these missing regulators, we measured the extent to which the remaining 11 candidates can improve the reprogramming of Zfp238/Myt1l-iN cells. We expressed Zfp238, Myt1l, and each of the 11 factors separately in MEFs and found that Lmo2, Rfx1, and Tcfl5 significantly improved the generation of iN cells ( Figures 7D, 7G, and 7H ). These results suggest that these three transcription factors act in parallel to Zfp238 and together execute the BAM-induced program leading to iN cell formation ( Figure S7D ).
DISCUSSION ''On-Target'' Pioneer Factor Activity of Ascl1
The dominant model of lineage reprogramming is transcription factor cooperativity based on factor co-occupancy and mutual positive feedback loops-a concept put forward based on iPS cell reprogramming (Jaenisch and Young, 2008) . In fact a recent study confirmed this model by showing that Oct4, Sox2, Klf4, and c-Myc cooperatively bind to a vast number of the same enhancers in fibroblasts (Soufi et al., 2012) . Three of the four factors were also shown to bind sites predominantly in a nucleosomal configuration and hence were regarded pioneer factors. Importantly, though, the vast majority of binding sites were mislocalized as the proper targets appeared to be barred by large repressed chromatin domains enriched by H3K9me3 modification. The observed initial mistargeting of the reprogramming factors is a plausible explanation for the low efficiencies and slow kinetics of iPS cell reprogramming. By analogy, it could be assumed that other types of lineage reprogramming also involve transcription factor cooperativity and positive feedback activation (Vierbuchen and Wernig, 2012) .
In stark contrast, our investigation of transcription factor occupancy states in iN cell reprogramming has revealed a surprising asymmetry in the behavior of the three reprogramming factors. At the top of the hierarchy stands Ascl1, which we found could access nucleosomal DNA and-unlike Oct4-also immediately bound its authentic neuronal target genes across the fibroblast genome. The term ''pioneer factor'' has been used to describe transcription factors that can bind nucleosomal DNA as single factors as opposed to regular transcription factors that require cooperation (Zaret and Carroll, 2011) . Here, we propose the term ''on-target pioneer factor'' to refer to pioneer factors like Ascl1 that bind their cognate lineage-specific targets whether genomic sites are freely available or are nucleosome bound in heterotypic cell types. Supported by structural models, classic pioneer factors have been proposed to access the DNA from one side, leaving the opposite site available for histone interaction (Soufi et al., 2012; Zaret and Carroll, 2011) . In contrast, Ascl1-like any bHLH transcription factor-binds the two neighboring major groves of DNA as heterodimer in a fork-like pattern with its a-helical basic domain, excluding the possibility of simultaneous nucleosome binding (Ma et al., 1994) . Therefore, the mechanism of nucleosomal DNA access must be different between pioneer factors reported to date. Assuming nucleosomes are not static and pioneer factors have a higher DNA affinity than do histones, once target sites are bound, they might be barred from histone wrapping.
MyoD, one of the earliest reprogramming factors identified, is also a bHLH factor and was shown to create DNase-hypersensitive sites at myogenic promoters and eliminate nucleosome phasing in the Myogenin promoter in MEFs, suggesting pioneer factor activity (Gerber et al., 1997) . Whether MyoD can also act as an ''on-target'' pioneer factor requires more investigation. Its binding pattern in MEFs seems similar to muscle cells, but there is only a 30% overlap between binding in MEFs and the neurogenic P19 cell line after acute expression (Cao et al., 2010; Fong et al., 2012) .
In contrast, Brn2 and Myt1l clearly do not have pioneer factor activity as they access mostly open chromatin and play a less dominant role during the early stages of iN cell reprogramming. Brn2 is predominantly localized to different sites than in NPCs. Surprisingly, this mislocalization could not simply be explained by differential chromatin accessibility as the ''proper'' neural Brn2 targets were overall in an accessible state in MEFs. At least a portion of the mislocalized targets could be explained because Ascl1 recruited Brn2 to many of its targets.
The ''on-target'' pioneer property of Ascl1 versus ''off-target'' character of the iPS cell factors may very well explain the dramatically higher iN cell reprogramming efficiency of $20% within 2 weeks (Vierbuchen et al., 2010) . ''On-target'' capability could become a valuable criterion to identify the most efficient reprogramming factors to induce other cell lineages especially if no candidate factor has reprogramming activity on its own. Exploring whether the FoxA and GATA pioneer factors used for hepatocyte and cardiac reprogramming are also ''on-target'' factors would be interesting (Ieda et al., 2010; Huang et al., 2011) .
A Chromatin Signature Predicts Reprogramming Capacity Although Ascl1 acted as an on-target pioneer factor in fibroblasts, it did not do so in keratinocytes. Therefore, chromatin features other than nucleosome occupancy must influence this factor's access to chromatin. We discovered a unique ''trivalent'' chromatin signature-comprised of H3K4me1, H3K27ac, and H3K9me3-that predicts permissiveness for Ascl1 occupancy (G) (legend continued on next page) and iN cell reprogramming among various nonneural cell types. This permissive chromatin signature should be highly useful in choosing recipient cells for neural reprogramming ex vivo or in vivo for therapeutic purposes. The enrichment of a repressive mark was surprising, especially in light of the recent finding that H3K9 methylation sites are occluded for the iPS cell reprogramming factors (Soufi et al., 2012) . However, the colocalization of H3K4me1 and H3K9me3 has been suggested as a poised state for cell-typespecific enhancers in ESCs that are later activated, similar to the H3K4me3 and H3K27me3 ''bivalent'' domains (Bernstein et al., 2006; Zhu et al., 2012) . Hence, the trivalent signature described here may represent a remnant form of such early embryonic poised states.
Although the discovery of a pre-existing defined chromatin configuration that is associated with Ascl1 binding is intriguing, it is also evident that this trivalent mark cannot explain all Ascl1 binding. Presumably, nonchromatin factors, such as yet unknown cofactors, may be expressed to different levels in different cell types, impacting binding and transcriptional activity of the reprogramming factors. In addition, only a small fraction of the thousands of binding sites could be functionally relevant and the accessibility to those sites may explain the vast majority of the variation in reprogramming efficiencies between cell types despite similar global responses.
A Distinct Cascade of Transcription Factors Mediating Neuronal Reprogramming
The interplay of Ascl1 and Zfp238 and other targets is yet another aspect of the hierarchical organization of iN cell reprogramming. First, based on binding and transcriptional data Ascl1 is the direct upstream activator of Zfp238. Second, Zfp238 executes an important but only a part of the lineage-specification program of Ascl1, as we found three additional transcription factors that cooperate with Zfp238 to generate iN cells. Hence, out of the thousands of target genes, only a handful appears to be critical for neuronal reprogramming. This conclusion may be helpful to enable reprogramming of thus far resistant cell types, such as keratinocytes. Collectively, our results suggest that iN cell reprogramming is a powerful tool to interrogate transcription factor function and to uncover transcriptional networks in neuronal lineage specification.
EXPERIMENTAL PROCEDURES
Cell Derivation, Culture, and Viral Production TauEGFP MEFs were isolated, and lentivirus was produced as previously described (Vierbuchen et al., 2010) . ES cell-derived NPCs (line NS5) were obtained from A. Smith, Cambridge, UK, and cultured as previously reported (Conti et al., 2005) . To establish Ascl1-inducible MEFs, we first generated a Rosa26 CAGGS-M2rtTA-T2A-puro ES cell line by homologous recombination and infected this with a TetO-flagAscl1 lentivirus. A subclone showing robust induction was then injected into blastocysts to generate chimeric embryos for MEF isolation. More detailed information can be found in the Extended Experimental Procedures.
Expression Analysis, Chromatin Immunoprecipitation, and FAIRE-Seq Total RNA was isolated and Poly-A selected. Libraries were prepared, and sequencing reads (100 bp) were generated on Hi-Seq 2000 Illumina platforms. Paired-end reads were aligned to the mouse reference sequence NCBI Build 37/mm9. Expression levels of RefSeq-annotated genes were calculated in unit of fragments per kilobase of exon model per million mapped fragments (FPKM). Differential expression analysis was performed using Student's t test function ''t.test'' in R, and genes with a p value < 0.05 and at least 2-fold expression change were defined as significant. Gene ontology analysis was performed using DAVID (david.abcc.ncifcrf.gov). ChIP-qPCR and ChIP-seq were carried out in Ascl1-and BAM-infected MEFs 48 hr after dox, and in uninfected or Ascl1-infected NPCs 18 hr after induction. Cells were infected with a pool of Ascl1, V5-or FLAG-tagged Brn2, and V5-or FLAG-tagged Myt1l, and the transgenes were induced with dox the day after. A list of antibodies used and detailed experimental procedures, including ChIP co-IP and primary computational analysis, can be found in the Extended Experimental Procedures. Formaldehyde-assisted isolation of regulatory elements (FAIREseq) followed the previously described method (Giresi et al., 2007) .
Computational Analysis
To identify chromatin states, we used the ChromHMM software (v. 1.06) according to Ernst and Kellis (2012) . A self-developed script was used to calculate the percentage of genomic bases within a ±200 bp window at the top 1,000 transcription factor peak summits that were occupied by the given state. To obtain the normalized frequency of Ascl1 peaks in each state, the total number of Ascl1 peaks in each state was divided by the length of the corresponding state's segmentation size and multiplied by 1 megabases (Mb). The principal component analysis was performed using the PCA package in Microsoft Excel's statistical add-in ''XLSTAT.'' Electrophysiology Whole-cell patches were established at room temperature using manipulators and amplifiers controlled by Clampex 10 Data Acquisition Software (Molecular Devices). Resting membrane potential, input resistance, and capacitance were recorded for every cell. The current clamp mode was used to record action potentials. We set the initial resting membrane potential (Vrest) to À60 mV using a small, constant holding current and applied current-pulses of 10-50 pA with a step-size of 10 pA, to test the ability to generate action potentials. Statistical comparisons between cumulative plots were made using the K-S (Kolmogorov-Smirnov) test.
ACCESSION NUMBERS
The GEO repository accession number for the ChIP-and RNA-sequenced tags reported in this paper is GSE43916. The accession numbers of publicly available data sets used in this study are reported in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental information includes Extended Experimental Procedures and seven figures and can be found with this article online at http://dx.doi.org/ 10.1016/j.cell.2013.09.028.
